Fred Alger Management, LLC Iveric Bio, Inc. Transaction History

Fred Alger Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$17.24 - $23.95 $145,764 - $202,497	8,455 New	8,455 $181,000
Q2 2022 Aug 15, 2022	SELL	$9.12 - $18.9 $3.15 Million - $6.54 Million	-345,881 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$12.15 - $16.83 $1.34 Million - $1.85 Million	-110,035 Reduced 24.13%	345,881 $5.82 Million
Q4 2021 Feb 14, 2022	SELL	$13.83 - $18.78 $961,572 - $1.31 Million	-69,528 Reduced 13.23%	455,916 $7.62 Million
Q3 2021 Nov 15, 2021	BUY	$7.07 - $17.5 $3.71 Million - $9.2 Million	525,444 New	525,444 $8.53 Million

250K

40K

Ticker ISEE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,078,000
Description
IVERIC bio, Inc., a biopharmaceutical company, discovers and develops novel treatments for retinal diseases with a focus on age-related and orphan inherited retinal diseases (IRDs). The company develops Zimura, an inhibitor of complement factor C5 comprising GATHER1, which has completed Phase 2/3 clinical trial; and GATHER2 that is in Phase 3 cl...

Get notified when there are updates to the investment portfolio of Fred Alger Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Fred Alger Management, LLC with notifications on news.